CAMLINFINE

Camlin Fine Sciences Share PriceCamlin Fine Sciences

₹136.6
1.15 (0.85%)
As on 03 December, 2023 | 07:30 BSE: 532834 NSE: CAMLINFINEISIN: INE052I01032

Camlin Fine Sciences Performance

Day Range

  • Low 136.05
  • High 139.50
₹ 136.6

52 Week Range

  • Low 124.05
  • High 186.35
₹ 136.6
  • Open Price138.00
  • Previous Close135.45
  • Volume670485

Start SIP in Camlin Fine Sciences

Start SIP

Camlin Fine Sciences Share Price

  • Over 1 Month -0.8%
  • Over 3 Month -21.31%
  • Over 6 Month -20.33%
  • Over 1 Year -13.35%

Camlin Fine Sciences Key Statistics

P/E Ratio 77.9
PEG Ratio -1.5
Market Cap Cr 2,287
Price to Book Ratio 3
EPS 2.9
Dividend 0
Relative Strength Index 50.84
Money Flow Index 67.81
MACD Signal -5.89
Average True Range 4.53

Camlin Fine Sciences Investment Rating

  • Master Rating:
  • Camlin Fine Sciences has an operating revenue of Rs. 1,640.03 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 5% is okay, ROE of 6% is fair but needs improvement. The company has a debt to equity of 54%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 70 which is a FAIR score but needs to improve its earnings, a RS Rating of 7 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 152 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Camlin Fine Sciences Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 206161218173243155201
Operating Expenses Qtr Cr 185136184145201140170
Operating Profit Qtr Cr 21253428421531
Depreciation Qtr Cr 1212118777
Interest Qtr Cr 15121312161610
Tax Qtr Cr 11441206
Net Profit Qtr Cr -1681619516
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 818704
Operating Expenses Annual Cr 662608
Operating Profit Annual in Cr 12877
Depreciation Cr 3327
Interest Annual Cr 5733
Tax Annual Cr 1910
Net Profit Annual Cr 4826
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1947
Cash from Investing Activity Annual Cr -115-172
Cash from Financing Annual Activity Cr 78129
Net Cash Flow Annual Cr -183
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 639589
Fixed Assets Annual Cr 611511
Total Non Current Assets Annual Cr 718625
Total Current Assets Annual Cr 876721
Total Assets Annual Cr 1,5941,346
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 4138
ROE Annual % 74
ROCE Annual % 138
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2014
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 406420427388483384389
Operating Expenses Qtr Cr 381381383338428337365
Operating Profit Qtr Cr 25394450554724
Depreciation Qtr Cr 19191816141416
Interest Qtr Cr 20101012181910
Tax Qtr Cr 945916117
Net Profit Qtr Cr -191692413615
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,6871,445
Operating Expenses Annual Cr 1,4761,259
Operating Profit Annual in Cr 205153
Depreciation Cr 6356
Interest Annual Cr 5936
Tax Annual Cr 4134
Net Profit Annual Cr 5261
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 51145
Cash from Investing Activity Annual Cr -125-249
Cash from Financing Annual Activity Cr 60136
Net Cash Flow Annual Cr -1432
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 816745
Fixed Assets Annual Cr 848763
Total Non Current Assets Annual Cr 972907
Total Current Assets Annual Cr 1,088894
Total Assets Annual Cr 2,0601,800
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 5249
ROE Annual % 79
ROCE Annual % 1211
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1313

Camlin Fine Sciences Technicals

EMA & SMA

Current Price
₹136.6
1.15 (0.85%)
pointer
  • Bullish Moving Average
  • ___
  • 8
  • Bearish Moving Average
  • ___
  • 8
  • 20 Day
  • ₹133.63
  • 50 Day
  • ₹142.91
  • 100 Day
  • ₹149.81
  • 200 Day
  • ₹151.91
  • 20 Day
  • ₹130.92
  • 50 Day
  • ₹147.04
  • 100 Day
  • ₹153.79
  • 200 Day
  • ₹155.40

Camlin Fine Sciences Resistance and Support

PIVOT
₹137.39
Resistance
First Resistance 138.72
Second Resistance 140.83
Third Resistance 142.17
RSI 50.84
MFI 67.81
MACD Single Line -5.89
MACD -4.26
Support
First Resistance 135.27
Second Resistance 133.93
Third Resistance 131.82

Camlin Fine Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 786,600 34,036,182 43.27
Week 1,599,819 64,152,742 40.1
1 Month 732,930 35,679,016 48.68
6 Month 740,662 41,299,286 55.76

Camlin Fine Sciences Result Highlights

Camlin Fine Sciences Synopsis

NSE-Chemicals-Specialty

Camlin Fine Sciences is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 789.44 Cr. and Equity Capital is Rs. 15.71 Cr. for the Year ended 31/03/2023. Camlin Fine Sciences Ltd. is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74100MH1993PLC075361 and registration number is 075361.
Market Cap 2,287
Sales 758
Shares in Float 8.71
No of funds 48
Yield 0.47
Book Value 3.36
U/D Vol ratio 0.7
LTDebt / Equity 46
Alpha -0.09
Beta 1.08

Camlin Fine Sciences

Owner NameSep-23Jun-23May-23Mar-23
Promoters 48.03%16.52%16.47%17.55%
Mutual Funds 2.74%8.45%10.01%11.6%
Foreign Portfolio Investors 1.61%10.11%9.89%10.18%
Financial Institutions/ Banks
Individual Investors 33.23%30.41%29.63%31.34%
Others 14.39%34.51%34%29.33%

Camlin Fine Sciences Management

Name Designation
Mr. Ashish Dandekar Chairman & Managing Director
Mr. Nirmal Momaya Managing Director
Mr. Arjun Dukane Executive Director
Mr. Mahabaleshwar Palekar Independent Director
Mr. Pradip Kanakia Independent Director
Mr. Amol Shah Independent Director
Mr. Sutapa Banerjee Independent Director
Mr. Joseph Conrad D'souza Independent Director
Ms. Anagha Dandekar Non Exe.Non Ind.Director
Mr. Harsha Raghavan Non Exe.Non Ind.Director

Camlin Fine Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Camlin Fine Sciences Corporate Action

Date Purpose Remarks
2023-11-06 Quarterly Results
2023-08-11 Quarterly Results
2023-05-22 Audited Results
2023-02-13 Quarterly Results
2022-11-12 Quarterly Results

Camlin Fine Sciences MF Shareholding

Name Amount(cr)
SBI Flexicap Fund Regular Growth 17,570
ICICI Prudential Smallcap Fund Growth 6,003
ICICI Prudential Dividend Yield Equity Fund Growth 2,665
Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 461
Groww Nifty Total Market Index Fund Regular Growth 32

Camlin Fine Sciences FAQs

What is Share Price of Camlin Fine Sciences ?

Camlin Fine Sciences share price is ₹136 As on 03 December, 2023 | 07:16

What is the Market Cap of Camlin Fine Sciences ?

The Market Cap of Camlin Fine Sciences is ₹2287.4 Cr As on 03 December, 2023 | 07:16

What is the P/E ratio of Camlin Fine Sciences ?

The P/E ratio of Camlin Fine Sciences is 77.9 As on 03 December, 2023 | 07:16

What is the PB ratio of Camlin Fine Sciences ?

The PB ratio of Camlin Fine Sciences is 3 As on 03 December, 2023 | 07:16

Q2FY23